Literature DB >> 10915005

Usefulness of quick intraoperative measurements of intact parathyroid hormone in the surgical management of hyperparathyroidism.

H Yamashita1, S Noguchi, T Futata, T Mizukoshi, S Uchino, S Watanabe, A Ohshima, T Murakami, K Inomata, H Yamashita1.   

Abstract

We investigated the use of quick measurement of intraoperative intact parathyroid hormone (I-PTH) to predict the outcome of parathyroidectomy. We examined intraoperative monitoring of I-PTH in 34 consecutive primary hyperparathyroidism (pHPT) patients operated on between April and December 1999. The average patient age was 56 +/- 13 years, and all but one were women. Four had a history of thyroidectomy. Blood samples were drawn before excision of enlarged parathyroid gland(s) and at 2, 5, 10, and 15 minutes afterward. Plasma I-PTH was measured by a two-site immunochemiluminometric assay. Twenty-three patients were shown to have single gland disease, and ten had multiglandular disease. All patients, except one, underwent successful parathyroidectomies. The plasma I-PTH value 15 minutes after removal of enlarged gland(s) had dropped to 26 +/- 10% of pre-excision I-PTH value. In one patient with a previous history of thyroidectomy for thyroid papillary cancer, no gland enlargement was found in the area where the lesion had been suggested by both ultrasonography and 99mTc sestamibi scanning. In this case, intraoperative measurements of I-PTH in the bilateral internal jugular veins identified an ectopic parathyroid tumor, which was successfully removed. We conclude that quick measurement of intraoperative I-PTH is a valuable tool for decision-making, especially for reoperative parathyroid surgery, for patients with previous history of thyroidectomy, and for patients in whom unilateral neck exploration or a single-gland approach is scheduled based upon preoperative localization.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10915005     DOI: 10.1016/s0753-3322(00)80025-6

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  6 in total

1.  Sequential changes in plasma intact and whole parathyroid hormone levels during parathyroidectomy for secondary hyperparathyroidism.

Authors:  Hiroyuki Yamashita; Tom Cantor; Shinya Uchino; Shin Watanabe; Takahiro Ogawa; Taiki Moriyama; Yuji Takamatsu; Masafumi Fukagawa; Shiro Noguchi
Journal:  World J Surg       Date:  2005-02       Impact factor: 3.352

2.  Parathyroid surgical failures with misleading falls of intraoperative parathyroid hormone levels.

Authors:  J Horányi; L Duffek; R Szlávik; K Darvas; P Lakatos; M Tóth; K Rácz
Journal:  J Endocrinol Invest       Date:  2003-11       Impact factor: 4.256

3.  Role of cyclase activating parathyroid hormone (1-84 PTH) measurements during parathyroid surgery: potential improvement of intraoperative PTH assay.

Authors:  Hiroyuki Yamashita; Ping Gao; Shiro Noguchi; Tom Cantor; Shinya Uchino; Shin Watanabe; Hiroto Yamashita; Hitoshi Kawamoto; Masafumi Fukagawa
Journal:  Ann Surg       Date:  2002-07       Impact factor: 12.969

4.  Intraoperative parathyroid hormone levels measured by intact and whole parathyroid hormone assays in patients with Graves' disease.

Authors:  Masaya Kai; Hiroyuki Yamashita; Tom Cantor; Taiki Moriyama; Masae Rai; Takahiro Ogawa; Shin Watanabe; Shinya Uchino; Shiro Noguchi
Journal:  Surg Today       Date:  2008-02-29       Impact factor: 2.549

5.  Thyroid cancer incidence in simultaneous thyroidectomy with parathyroid surgery.

Authors:  Selman Emirikçi; Beyza Özçınar; Gizem Öner; Nail Omarov; Orhan Ağcaoğlu; Yiğit Soytaş; Nihat Aksakal; Fatih Yanar; Umut Barbaros; Yeşim Erbil
Journal:  Ulus Cerrahi Derg       Date:  2015-08-18

6.  Intraoperative parathyroid hormone assay in patients with Graves' disease for prediction of postoperative tetany.

Authors:  Taiki Moriyama; Hiroyuki Yamashita; Shiro Noguchi; Yuji Takamatsu; Takahiro Ogawa; Shin Watanabe; Shinya Uchino; Akira Ohshima; Syoji Kuroki; Masao Tanaka
Journal:  World J Surg       Date:  2005-10       Impact factor: 3.282

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.